Artelo Biosciences (ARTL) Long-Term Investments (2021 - 2024)

Artelo Biosciences (ARTL) has reported Long-Term Investments for 4 consecutive years, with $500000.0 the latest figure, recorded in Q3 2024.

• In Q3 2024, Long-Term Investments fell 95.11% year-over-year to $500000.0; the TTM figure through Sep 2024 stood at $500000.0 (down 95.11% YoY), while the FY2023 annual figure was $7.6 million, down 16.82% from the prior year.
• Long-Term Investments fell to $500000.0 in Q3 2024 per ARTL's latest filing, from $7.6 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $10.2 million in Q3 2023 and bottomed at $500000.0 in Q3 2024.
• Historically, Long-Term Investments has averaged $5.8 million across 4 years, with a median of $7.6 million in 2023.
• Annual changes were most pronounced in 2023 — Long-Term Investments declined 16.82% — and 2024, when it tumbled 95.11%.
• Artelo Biosciences' Long-Term Investments stood at $1.5 million in 2021, then soared by 500.39% to $9.2 million in 2022, then declined by 16.82% to $7.6 million in 2023, then sank by 93.43% to $500000.0 in 2024.
• Business Quant data shows ARTL's Long-Term Investments at $500000.0 in Q3 2024, $7.6 million in Q4 2023, and $10.2 million in Q3 2023.